Cargando…
Secondary myelodysplastic syndromes identified via next-generation sequencing in a non-small cell lung cancer patient
BACKGROUND: Myelodysplastic syndrome (MDS) is a group of clonal disorders characterized by ineffective and dysplastic hematopoiesis in the bone marrow with a high risk of progression to leukemia. Many studies have demonstrated that chemo-radiotherapy for cancer patients and exposure to certain chemi...
Autores principales: | Feng, Yongzhi, Chen, Xialin, Jiang, Keran, Zhang, Ding, Tao, Feng, Ni, Dan, Zhang, Jun, Wu, Lixin, Cai, Jinping, Jiang, Libin, Yu, GenHua, Shi, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691080/ https://www.ncbi.nlm.nih.gov/pubmed/34930266 http://dx.doi.org/10.1186/s12920-021-01147-y |
Ejemplares similares
-
Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencing
por: Xu, Yuanyuan, et al.
Publicado: (2017) -
Simultaneous Monitoring of Mutation and Chimerism Using Next-Generation Sequencing in Myelodysplastic Syndrome
por: Lee, Jong-Mi, et al.
Publicado: (2019) -
The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan
por: Anwar, Nida, et al.
Publicado: (2021) -
Hyperuricemia and acute kidney injury secondary to spontaneous tumor lysis syndrome in low risk myelodysplastic syndrome
por: Feng, Yunlin, et al.
Publicado: (2014) -
Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series
por: Martin de Frémont, Grégoire, et al.
Publicado: (2021)